A recent study conducted by scientists at ESPOL has unveiled the biotechnological potential of microorganisms from Antarctica. In this remote continent, where life thrives under extreme conditions, researchers isolated 77 microbial strains from 162 cultures, identifying 49 species, predominantly actinomycetes (66.23%).